Physician profile
Zavier C Ash
NPI 1770569204
$2,435.17
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,424 · 2020: $180 · 2021: $154 · 2022: $279 · 2023: $234 · 2024: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $398.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $589.58 | 2019-2020 | |
| Lilly USA, LLC | $439.44 | 2019-2023 | Mounjaro, Jardiance |
| Novo Nordisk INC | $359.62 | 2019-2024 | Rybelsus, Ozempic |
| Sanofi-Aventis U.S. LLC | $249.73 | 2019 | |
| Glaxosmithkline, LLC. | $161.45 | 2022-2024 | Trelegy Ellipta |
| Pfizer INC. | $109.50 | 2020-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $69.29 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $58.19 | 2021-2023 | |
| Amarin Pharma, INC. | $57.02 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $56.55 | 2019 | |
| Dexcom, INC. | $53.05 | 2022-2023 | Dexcom G6 Transmitter |
| Medtronic, INC. | $51.76 | 2021-2022 | |
| Amgen INC. | $44.41 | 2024 | Krystexxa |
| Inspire Medical Systems, INC. | $42.62 | 2024 | Inspire |
| Janssen Pharmaceuticals, INC | $40.46 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $32.86 | 2023-2024 | Veozah |
| Astrazeneca Pharmaceuticals Lp | $19.64 | 2024 | Airsupra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zavier Ash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.